![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
MEDICINAL POTENTIAL OF BERGENIA CILIATE: REVIEW
Dr. Sanjay Kumar*, Kiran Thakur, Jatinder Kishour, Ritika Sharma, Sameena Akhtar and Sumit Sharma
ABSTRACT Bergenia (Saxifragaceae) includes 32 species in Central Asia. Nine are pharmacologically significant. "Pashanabheda" is an Ayurvedic concoction made from the rhizomes of the Indian medicinal plant B. ligulata. The Himalayas are home to some of the world's most rare medicinal herbs. Bergenia ciliata (Saxifragaceae) is a diuretic and antiurolithik herb. It is in peril due to habitat degradation and unsustainable resource extraction. Unsustainable use and chaotic markets are driving species from their natural habitats in this region. The Maximum Entropy approach was used to estimate species distribution in the Mussoorie area for conservation and management planning. Field survey data were utilised to predict B. ciliata distribution. The distribution was projected using bioclimatic and topographic data. Potential is classified as high, good, moderate, or low. There are also biological activities of Bergenia species such as hepatoprotective (hepatoprotective) and adaptogenic (adaptogenic). This study discusses Bergenia's traditional uses, phytochemistry, and medicinal value. Bergenia contains 152 chemical components, including polyphenols, phenolic-glycosides, lactones, quinones, sterols, tannins, terpenes, and others. Just B. crassifolia has 104 bioactive compounds. Through thorough pharmacological and phytochemical research, Bergenia species could yield more reliable chemicals and products of pharmacological importance for better healthcare. Keywords: Bergenia ciliata, Phytochemicals, Botanical description, Traditional uses, Pharmacology. [Download Article] [Download Certifiate] |